4893 items matching your search terms.

International randomised phase III study of capecitabine, bevacizumab and mitomycin C in first-line metastatic colorectal cancer: final results of the AGITG MAX trial

Tebbutt, NC Gebski, V Wilson, K Cummins, M Chua, Y Robinson, B Broad, A Cunningham, D Simes, J Price, T

International randomised phase III study of capecitabine, bevacizumab and mitomycin C in first line treatment of metastatic colorectal cancer: final results of the AGITG MAX trial

Tebbutt, N Gebski, V Wilson, K Cummins, M Robinson, B Broad, A Cunningham, D Simes, J Stockler, M Price, T

Risk predictors of first microvascular complications in type 2 diabetes mellitus: the FIELD study

Ting, RD Donoghoe, M Li, LP Davis, TM O'Connell, R Gebski, V Best, JD Kesaniemi, A Laakso, M Keech, AC FIELD Study Investigators,

Clinical and biochemical indicators of microvascular complications of type 2 diabetes mellitus: the FIELD study

Ting, R Li, LP Davis, TM Donoghoe, M Best, J Gebski, V Rajamani, K Keech, AC on behalf of the FIELD study investigators,

Examination of the mechanisms of osteolysis in patients with metastatic breast cancer

Trinkaus, M Ooi, WS Amir, E Popovic, S Kalina, M Kahn, H Singh, G Gainford, MC Clemons, M

Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?

Urwyler, N Staub, LP Beran, D Deplazes, M Lord, SJ Alberio, L Theiler, L Greif, R

Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized controlled trial

Urwyler, N Trelle, S Theiler, L Juni, P Staub, L Luyet, C Alberio, L Stricker, K Greif, R
TRIALS, 2009     DOI:doi:10.1186/1745-6215-10-107

Type of progression in patients treated with imatinib for advanced gastrointestinal stromal tumor: a study based on the EORTC-ISG-AGITG trial 62005

Van Glabbeke, MM Verweij, J Casali, P Zalcberg, J Le Cesne, A Reichardt, P Issels, R Judson, I Debiec-Rychter, M Blay, JY

Impact of Y-90 resin microspheres on health-related quality of life in patients with colorectal cancer liver metastases receiving first-line chemotherapy

Van Hazel, GA Turner, D Gebski, V

A GCIG randomized phase III study of carboplatin and pegylated liposomal doxorubicin vs carboplatin and paclitaxel: CALYPSO results in partially platinum-sensitive ovarian cancer patients

Vasey, P Largillier, R Gropp, M Gebski, V Sandvei, R Elit, L Angleitner-Boubezinek, L Reed, N Pignata, S Ferrero, AM

Uterine papillary serous carcinoma: patterns of failure and survival

Wang, W Do, V Hogg, R Wain, G Brand, A Bull, C Stenlake, A Gebski, V
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009     DOI:10.1111/j.1479-828X.2009.01016.x

Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation

Yeates, K. E. Cass, A. Sequist, T. D. McDonald, S. P. Jardine, M. J. Trpeski, L. Ayanian, J. Z.
KIDNEY INTERNATIONAL, 2009     DOI:10.1038/ki.2009.236

Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling

Zhao, L Lee, BY Brown, DA Molloy, MP Marx, GM Pavlakis, N Boyer, MJ Stockler, MR Kaplan, W Breit, SN Sutherland, RL Henshall, SM Horvath, LG
CANCER RESEARCH, 2009     DOI:10.1158/0008-5472.can-08-4901

Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy

Zoungas, S. Ninomiya, T. Huxley, R. Cass, A. Jardine, M. Gallagher, M. Patel, A. Vasheghani-Farahani, A. Sadigh, G. Perkovic, V.
ANNALS OF INTERNAL MEDICINE, 2009     DOI:10.7326/0003-4819-151-9-200911030-00008

Radiation therapists' perspective on barriers to clinical trials research

Agustin, C. Grand M. Gebski, Val Turner, S.